Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Hold
13,495
0.28% 77
2025
Q4
$905K Sell
13,495
-1,000
-7% -$64.7K 0.23% 86
2025
Q3
$980K Hold
14,495
0.26% 82
2025
Q2
$1.08M Hold
14,495
0.31% 71
2025
Q1
$912K Hold
14,495
0.26% 79
2024
Q4
$826K Hold
14,495
0.24% 82
2024
Q3
$852K Sell
14,495
-1,598
-10% -$87.3K 0.21% 83
2024
Q2
$868K Sell
16,093
-115
-0.7% -$6.33K 0.2% 86
2024
Q1
$935K Hold
16,208
0.24% 79
2023
Q4
$777K Buy
16,208
+351
+2% +$16.7K 0.21% 87
2023
Q3
$811K Sell
15,857
-55
-0.3% -$2.91K 0.28% 74
2023
Q2
$898K Hold
15,912
0.28% 72
2023
Q1
$973K Hold
15,912
0.32% 69
2022
Q4
$935K Hold
15,912
0.32% 68
2022
Q3
$909K Hold
15,912
0.35% 70
2022
Q2
$861K Hold
15,912
0.34% 73
2022
Q1
$915K Hold
15,912
0.34% 69
2021
Q4
$752K Sell
15,912
-64
-0.4% -$2.92K 0.27% 78
2021
Q3
$672K Sell
15,976
-63
-0.4% -$2.73K 0.28% 77
2021
Q2
$711K Hold
16,039
0.29% 79
2021
Q1
$748K Hold
16,039
0.33% 73
2020
Q4
$621K Hold
16,039
0.3% 77
2020
Q3
$462K Hold
16,039
0.25% 79
2020
Q2
$430K Hold
16,039
0.25% 81
2020
Q1
$377K Sell
16,039
-133
-0.8% -$3.66K 0.27% 80
2019
Q4
$478K Sell
16,172
-259
-2% -$6.86K 0.26% 79
2019
Q3
$460K Sell
16,431
-121
-0.7% -$3.5K 0.27% 79
2019
Q2
$489K Buy
+16,552
New +$445K 0.3% 78

Other funds holding CTVA

Searle & Co's CTVA Position: Q1 2026 in Review

Searle & Co held its Corteva (CTVA) position steady in Q1 2026 at 13,495 shares worth $1.13M. The position accounts for 0.28% of the portfolio, ranked #77.

Searle & Co first reported a position in CTVA in Q2 2019 and has held it in 28 quarters since. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Searle & Co held 13,495 shares of Corteva worth $1.13M as of Q1 2026.
  • Searle & Co left its Corteva share count unchanged in Q1 2026.
  • Corteva made up 0.28% of Searle & Co's portfolio in Q1 2026, its #77 holding.
  • Searle & Co first reported a position in Corteva in Q2 2019 and has held it in 28 quarters since.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Searle & Co's 13F filing for Q1 2026, filed 8 May 2026.